Baxter International, Inc. (NYSE:BAX)

CAPS Rating: 4 out of 5

The Company provides medical products and services. Its medical devices, pharmaceuticals and biotechnology assists healthcare professionals and their patients in the treatment of complex medical conditions.

Results 1 - 20 of 83 : 1 2 3 4 5 Next »

Recs

0
Member Avatar Buzpick (< 20) Submitted: 3/19/2016 6:22:40 PM : Outperform Start Price: $40.13 BAX Score: +11.99

Activist Investor 3rd point

Recs

0
Member Avatar Chemdawg (27.55) Submitted: 1/24/2016 4:42:07 AM : Outperform Start Price: $35.93 BAX Score: +17.66

magic stock with nice tailwinds behind it

Recs

0
Member Avatar gonelong (54.41) Submitted: 6/18/2015 4:00:54 PM : Outperform Start Price: $37.12 BAX Score: +24.61

DG50: http://seekingalpha.com/article/2764265-its-new-its-nifty-its-the-dividend-growth-50

Recs

0
Member Avatar pupowski (< 20) Submitted: 5/5/2015 7:56:55 PM : Outperform Start Price: $37.17 BAX Score: +23.56

well managed

Recs

0
Member Avatar MKBooie2004 (< 20) Submitted: 3/16/2014 3:13:11 PM : Outperform Start Price: $34.25 BAX Score: +21.28

Safe Haven Health Care with a increasing sustainable dividend. At my age slow gain is much better than no gain.

Recs

0
Member Avatar nicholas13 (58.04) Submitted: 1/17/2014 12:09:06 AM : Outperform Start Price: $35.86 BAX Score: +14.49

Solid business model, company culture lends itself to more innovation. One of the major players if not the company to beat in renal healthcare.

Recs

0
Member Avatar Lippoldtskivich (48.39) Submitted: 11/5/2013 12:35:34 PM : Outperform Start Price: $33.22 BAX Score: +19.79

Broadly solid market positions for a profitable range of medical products, with aging populations in many countries and, currently, an expanding population covered by health insurance in the US. This is a relatively good situation.

Recs

0
Member Avatar benyboy (< 20) Submitted: 10/24/2013 2:55:17 AM : Outperform Start Price: $33.46 BAX Score: +17.67

Jimy cramer bullish on current levels $65

Recs

0
Member Avatar PeteH66 (< 20) Submitted: 10/7/2013 1:39:43 PM : Outperform Start Price: $32.91 BAX Score: +14.89

I buy the case (made here: http://seekingalpha.com/article/1726822-is-baxter-international-oversold-should-dividend-investors-be-taking-notice?source=email_investing_income&ifp=0) that Baxter is oversold in reaction to Biogen's intro of a competing blot-clot drug.

Recs

0
Member Avatar wtcrane1 (94.33) Submitted: 8/7/2013 3:15:54 PM : Outperform Start Price: $36.17 BAX Score: +3.72

undervalued, wide moat

Recs

0
Member Avatar Jolon (< 20) Submitted: 1/12/2013 10:12:24 PM : Outperform Start Price: $34.37 BAX Score: -8.23

Baxter has solid p/e and I predict it has a bright future ahead

Recs

0
Member Avatar olbar (< 20) Submitted: 12/10/2012 8:17:53 PM : Outperform Start Price: $37.12 BAX Score: +22.83

Baxter International Inc., moving to strengthen its already-substantial presence in the global kidney-dialysis market, disclosed Tuesday that it has agreed to pay about $4 billion to acquire Swedish dialysis equipment maker Gambro AB.

Recs

0
Member Avatar Marlonito9 (< 20) Submitted: 9/7/2012 9:44:38 PM : Underperform Start Price: $29.75 BAX Score: -9.74

It really should specially in the long run. It's inevitable due to natural market direction.

Recs

0
Member Avatar ryanman000 (< 20) Submitted: 4/13/2012 7:45:26 PM : Outperform Start Price: $27.13 BAX Score: +17.61

Watching this

Recs

0
Member Avatar campwt00global (34.81) Submitted: 9/6/2011 10:59:17 AM : Outperform Start Price: $25.22 BAX Score: +0.73

9/6/2011 BNY port rotate out of OXY to BAX 8/17/2011 at 53.51 can buy today at 52.48

Recs

0
Member Avatar ferdicemara (< 20) Submitted: 5/10/2011 8:33:52 AM : Outperform Start Price: $28.17 BAX Score: +8.53

SUCCESS

Recs

0
Member Avatar Covestor (57.49) Submitted: 3/14/2011 3:05:39 PM : Underperform Start Price: $24.85 BAX Score: -23.69

Covestor Model Manager SWAN-asset management sold BAX in his Christian Agape Hedged Equity Covestor Model ( http://covestor.com/SWAN-asset-management )

Recs

0
Member Avatar Chris5038 (< 20) Submitted: 2/7/2011 9:06:30 AM : Outperform Start Price: $23.04 BAX Score: +39.90

Buying new companies

Recs

1
Member Avatar thenatural24 (56.01) Submitted: 9/18/2010 9:09:10 AM : Outperform Start Price: $21.20 BAX Score: +31.28

I think this is a classic value play (and has a 2.5% dividend to boot). BAX has shown solid earnings growth and FCF, has a history repurchasing shares, and is, in my opinion, temporaily depressed due to a macro slowdown in protein plasma and antibody therapy. This presents a great buying opportunity.

Recs

0
Member Avatar jncgator (< 20) Submitted: 8/22/2010 12:27:41 PM : Underperform Start Price: $20.96 BAX Score: -25.59

This stock will eventually turn out in good shape from its recall on infusion pumps, but for now it should return to the 40 dollar per share range

Results 1 - 20 of 83 : 1 2 3 4 5 Next »

Featured Broker Partners